Supplemental Table 2 from Comparing Patient-Derived Xenograft and Computational Response Prediction for Targeted Therapy in Patients of Early-Stage Large Cell Lung Cancer

Abstract

<p>Downregulation of MSM components based on erlotinib treatment</p>